Strengthening High Quality Laboratory Services Scale-Up for HIV Diagnosis, Care, Treatment and Monitoring in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 155103CONT17

Opportunity Information: Apply for CDC RFA GH15 155103CONT17

This funding opportunity, titled "Strengthening High Quality Laboratory Services Scale-Up for HIV Diagnosis, Care, Treatment and Monitoring in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a U.S. government grant announcement issued by the Department of Health and Human Services (HHS) through the Centers for Disease Control and Prevention (CDC), specifically within CDC's Center for Global Health (CGH). The opportunity is focused on improving and expanding laboratory services that support HIV prevention, diagnosis, clinical care, antiretroviral treatment, and ongoing patient monitoring in Malawi, aligning with PEPFAR priorities to strengthen national systems and improve HIV outcomes.

The announcement is identified by Funding Opportunity Number CDC RFA GH15 155103CONT17 and is categorized as a "Continuation" opportunity. That category typically indicates the funding is intended to continue or extend work that is already underway under an existing project or program, rather than launching an entirely new initiative. The funding instrument is a Cooperative Agreement, which generally means CDC expects to have substantial involvement in the work beyond standard grant oversight. In practice, that often includes close technical collaboration, joint planning, and ongoing programmatic engagement to ensure the activities meet public health objectives and align with CDC and PEPFAR strategies.

The activity category is listed as Health, and the CFDA number associated with the opportunity is 93.067, which corresponds to a CDC global health assistance program area. The core theme is scaling up high-quality laboratory services, which in the HIV context commonly includes strengthening testing networks, improving access to reliable diagnostic tools, ensuring quality assurance systems, building workforce capacity, and improving laboratory management and data systems. For Malawi, this kind of support typically aims to ensure that HIV testing and clinical monitoring are accurate, timely, and accessible across different levels of the health system, including central reference laboratories, regional labs, and peripheral facilities.

The notice indicates an ExpectedAwards figure of 10, suggesting CDC anticipated supporting multiple awards or multiple funded components under the continuation framework. The AwardCeiling is listed as 0, which usually means the ceiling was not specified in the posted summary or was to be determined based on available funds, negotiations, or continuation award structures. The posting was created on October 10, 2016, with an original closing date of December 13, 2016, reflecting the window during which eligible applicants could submit materials for consideration.

Eligibility is described as "Others (see text field entitled Additional Information on Eligibility for clarification)." While the detailed eligibility language is not included in the excerpt you provided, that phrasing generally implies that eligibility may be limited to certain types of organizations or potentially to incumbent awardees or specific partners, especially given the continuation nature of the announcement. In many CDC cooperative agreements under PEPFAR, eligible entities can include non-profit organizations, universities, implementing partners, and sometimes other public or private entities, but the exact eligible applicant pool depends on the full notice.

Overall, the opportunity is aimed at reinforcing Malawi's laboratory systems as a backbone for HIV program performance under PEPFAR, with an emphasis on scaling services and maintaining high quality so that HIV diagnosis and patient monitoring can support effective treatment decisions, track program success, and ultimately improve health outcomes.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Strengthening High Quality Laboratory Services Scale-Up for HIV Diagnosis, Care, Treatment and Monitoring in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Oct 10, 2016.
• Applicants must submit their applications by Dec 13, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH15 155103CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: